Latest news
HALOZYME THERAPEUTICS, INC. : LEERINK PARTNERS RAISES TO OUTPERFORM FROM MARKET PERFORM; RAISES TARGET PRICE TO $110 FROM $83 - BitgetBitget · Fri, 07 Aug 2026 14:59:35 GMTDoximity, Inc. : Leerink Partners Raises Targ - MoomooMoomoo · Fri, 07 Aug 2026 11:05:56 GMTEXELIXIS INC : LEERINK PARTNERS CUTS TO MARKET PERFORM FROM OUTPERFORM - BitgetBitget · Fri, 07 Aug 2026 04:55:12 GMTINSMED INC : LEERINK PARTNERS RAISES TARGET PRICE TO $210.00 FROM $205.00 - BitgetBitget · Fri, 07 Aug 2026 04:52:20 GMTJFROG LTD : RAYMOND JAMES RAISES TARGET PRICE TO $120 FROM $80 - BitgetBitget · Fri, 07 Aug 2026 03:38:28 GMTImportant to Give Guidance in Current Market, ResMed CEO Says - BitgetBitget · Fri, 07 Aug 2026 02:46:29 GMTPROTAGONIST THERAPEUTICS, INC. : LEERINK PARTNERS RAISES TARGET PRICE TO $150.00 FROM $110.00 - BitgetBitget · Thu, 06 Aug 2026 16:16:59 GMTSPYRE THERAPEUTICS INC : LEERINK PARTNERS RAISES TARGET PRICE TO $124 FROM $106 - webull.comwebull.com · Thu, 06 Aug 2026 05:28:45 GMT